Target Validation Information
TTD ID T14908
Target Name Ceramide glucosyltransferase (UGCG)
Type of Target
Successful
Drug Potency against Target Miglustat Drug Info IC50 = 50000 nM [2]
N-butylgalactonojirimycin Drug Info IC50 = 5300 nM [1]
References
REF 1 Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis. J Biol Chem. 2007 Nov 9;282(45):32655-64.
REF 2 Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet. 2000 Apr 29;355(9214):1481-5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.